BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26726340)

  • 1. Incidence, Survival, and Mortality of Malignant Cutaneous Melanoma in Wisconsin, 1995-2011.
    Peterson M; Albertini MR; Remington P
    WMJ; 2015 Oct; 114(5):196-201. PubMed ID: 26726340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in malignant melanoma incidence and mortality in Wisconsin, 1979-1997.
    Insinga RP; Reither EN; Remington PL; Stephenson-Vine L
    WMJ; 2001; 100(6):27-31. PubMed ID: 11688336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
    Jones ME; Shugg D; Dwyer T; Young B; Bonett A
    Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania.
    Stang A; Valiukeviciene S; Aleknaviciene B; Kurtinaitis J
    Eur J Cancer; 2006 Mar; 42(5):660-7. PubMed ID: 16510281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006.
    Jemal A; Saraiya M; Patel P; Cherala SS; Barnholtz-Sloan J; Kim J; Wiggins CL; Wingo PA
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S17-25.e1-3. PubMed ID: 22018063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, mortality and survival in cutaneous melanoma.
    Giblin AV; Thomas JM
    J Plast Reconstr Aesthet Surg; 2007; 60(1):32-40. PubMed ID: 17126264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study.
    MacKie RM; Bray CA; Hole DJ; Morris A; Nicolson M; Evans A; Doherty V; Vestey J;
    Lancet; 2002 Aug; 360(9333):587-91. PubMed ID: 12241928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
    MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
    BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the incidence and mortality rates of malignant melanoma in the Seine-Maritime region over a 20-year period].
    Le Blanc C; Corven C; Courville P; Duval-Modeste AB; Boivin C; Ziadé J; De Mauroy C; Pellerin A; Bokanowski H; Dalibard F; Gremain J; Roquet ML; Chenal P; Ducastelle T; Vaquer JM; Benichou J; Joly P
    Ann Dermatol Venereol; 2013 Feb; 140(2):97-104. PubMed ID: 23395490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality trends in cutaneous malignant melanoma in Spain, 1967-1986.
    Pollán M; López-Abente G
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):545-50. PubMed ID: 8268771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
    McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
    Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
    Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
    J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma: trends in Wisconsin, 1980-1989.
    Byers RL; Lantz PM; Remington PL; Phillips JL
    Wis Med J; 1991 Jun; 90(6):305, 307. PubMed ID: 1871997
    [No Abstract]   [Full Text] [Related]  

  • 16. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007.
    Feng Z; Wu X; Chen V; Velie E; Zhang Z
    J Cutan Pathol; 2011 Aug; 38(8):616-24. PubMed ID: 21518379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma epidemic: Facts and controversies.
    Erickson C; Driscoll MS
    Clin Dermatol; 2010; 28(3):281-6. PubMed ID: 20541680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions.
    Geller AC; Swetter SM; Brooks K; Demierre MF; Yaroch AL
    J Am Acad Dermatol; 2007 Oct; 57(4):555-72; quiz 573-6. PubMed ID: 17870429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.